Chemotherapy and Immunotherapy as Treatment for MSS Metastatic Colorectal Cancer With High Immune Infiltrate

NCT04262687 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer Metastatic
High Immune Infiltrate
Microsatellite Stable

Interventions

DRUG: Capecitabine
DRUG: Oxaliplatin
DRUG: Bevacizumab
DRUG: Pembrolizumab

Sponsor

Federation Francophone de Cancerologie Digestive